JP2021513547A5 - - Google Patents

Info

Publication number
JP2021513547A5
JP2021513547A5 JP2020543286A JP2020543286A JP2021513547A5 JP 2021513547 A5 JP2021513547 A5 JP 2021513547A5 JP 2020543286 A JP2020543286 A JP 2020543286A JP 2020543286 A JP2020543286 A JP 2020543286A JP 2021513547 A5 JP2021513547 A5 JP 2021513547A5
Authority
JP
Japan
Prior art keywords
compound according
alkyl
halo
cyano
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020543286A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021513547A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/017881 external-priority patent/WO2019160980A1/en
Publication of JP2021513547A publication Critical patent/JP2021513547A/ja
Publication of JP2021513547A5 publication Critical patent/JP2021513547A5/ja
Pending legal-status Critical Current

Links

JP2020543286A 2018-02-14 2019-02-13 ソベチロムの誘導体 Pending JP2021513547A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862630775P 2018-02-14 2018-02-14
US62/630,775 2018-02-14
US201862631442P 2018-02-15 2018-02-15
US62/631,442 2018-02-15
PCT/US2019/017881 WO2019160980A1 (en) 2018-02-14 2019-02-13 Derivatives of sobetirome

Publications (2)

Publication Number Publication Date
JP2021513547A JP2021513547A (ja) 2021-05-27
JP2021513547A5 true JP2021513547A5 (cg-RX-API-DMAC7.html) 2022-02-17

Family

ID=67619583

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020543286A Pending JP2021513547A (ja) 2018-02-14 2019-02-13 ソベチロムの誘導体

Country Status (11)

Country Link
US (1) US11578032B2 (cg-RX-API-DMAC7.html)
EP (1) EP3752001A4 (cg-RX-API-DMAC7.html)
JP (1) JP2021513547A (cg-RX-API-DMAC7.html)
KR (1) KR20200120928A (cg-RX-API-DMAC7.html)
CN (1) CN111818798A (cg-RX-API-DMAC7.html)
AU (1) AU2019222709A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020016599A2 (cg-RX-API-DMAC7.html)
CA (1) CA3091021A1 (cg-RX-API-DMAC7.html)
IL (1) IL276592B2 (cg-RX-API-DMAC7.html)
MX (1) MX2020008498A (cg-RX-API-DMAC7.html)
WO (1) WO2019160980A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3894383A1 (en) * 2018-12-12 2021-10-20 Autobahn Therapeutics, Inc. Novel thyromimetics
CA3130371A1 (en) 2019-03-01 2020-09-10 Autobahn Therapeutics, Inc. Novel thyromimetics
CN115279359A (zh) 2019-11-29 2022-11-01 速通医疗公司 新型拟甲状腺素药
WO2021247847A1 (en) * 2020-06-03 2021-12-09 Autobahn Therapeutics, Inc. Isotopic thyromimetic compounds
WO2021257834A1 (en) * 2020-06-17 2021-12-23 Autobahn Therapeutics, Inc. Thyromimetics
EP4168384A4 (en) * 2020-06-17 2024-07-10 Autobahn Therapeutics, Inc. THYROMIMETICS
EP4167986A4 (en) 2020-06-17 2024-11-20 Autobahn Therapeutics, Inc. THYROMIMETICS
AU2022271304A1 (en) * 2021-05-06 2023-11-23 Autobahn Therapeutics, Inc. Fatty acid amide hydrolase (faah) cleavable prodrugs of thyromimetics and combination with peripherally restricted faah inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883294A (en) 1997-06-18 1999-03-16 The Regeants Of The University Of California Selective thyroid hormone analogs
US6436990B1 (en) * 1999-10-27 2002-08-20 Nobex Corporation 6-methoxy-2-naphthylacetic acid prodrugs
US6429223B1 (en) * 2000-06-23 2002-08-06 Medinox, Inc. Modified forms of pharmacologically active agents and uses therefor
US20090232879A1 (en) * 2005-05-26 2009-09-17 Metabasis Therapeutics, Inc. Thyromimetics for the Treatment of Fatty Liver Diseases
RU2007148927A (ru) 2005-05-26 2009-07-10 Метабэйзис Терапьютикс, Инк. (Us) Новые тиреомиметики, содержащие фосфиновую кислоту
PE20180021A1 (es) 2015-02-20 2018-01-09 Univ Oregon Health & Science Derivados de sobetiroma
WO2017015360A1 (en) * 2015-07-20 2017-01-26 Oregon Health & Science University Quinolone-3-diarylethers
MX382313B (es) * 2016-05-18 2025-03-13 Univ Oregon Health & Science Derivados del sobetiroma.
US11325886B2 (en) * 2016-08-12 2022-05-10 Oregon Health & Science University Amide compounds, pharmaceutical compositions thereof, and methods of using the same

Similar Documents

Publication Publication Date Title
JP2024514703A5 (cg-RX-API-DMAC7.html)
JP2020023528A5 (cg-RX-API-DMAC7.html)
JP2021191784A5 (cg-RX-API-DMAC7.html)
JP2015024998A5 (cg-RX-API-DMAC7.html)
JP2018070614A5 (cg-RX-API-DMAC7.html)
JP2022513449A5 (cg-RX-API-DMAC7.html)
JP2005523922A5 (cg-RX-API-DMAC7.html)
MX2022006470A (es) Tiromimeticos novedosos.
JP2003530432A5 (cg-RX-API-DMAC7.html)
CA2563743A1 (en) New pharmaceutical compositions for the treatment of sexual disorders ii
JP2016515561A5 (cg-RX-API-DMAC7.html)
JP2006518328A5 (cg-RX-API-DMAC7.html)
JP2017536395A5 (cg-RX-API-DMAC7.html)
JP2019520344A5 (cg-RX-API-DMAC7.html)
JP2022500425A5 (cg-RX-API-DMAC7.html)
JP2018507886A5 (cg-RX-API-DMAC7.html)
JP2017512211A5 (cg-RX-API-DMAC7.html)
JPWO2023195529A5 (cg-RX-API-DMAC7.html)
RU2016136193A (ru) Аминокарбонилкарбаматные соединения
JP2022508513A5 (cg-RX-API-DMAC7.html)
JP2020504184A5 (cg-RX-API-DMAC7.html)
JP2015504917A5 (cg-RX-API-DMAC7.html)
JP2025142197A5 (cg-RX-API-DMAC7.html)
JP2020519659A5 (cg-RX-API-DMAC7.html)
JP2021503451A5 (cg-RX-API-DMAC7.html)